Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthcare Services (HCSG) EBITDA: 2009-2024

Historic EBITDA for Healthcare Services (HCSG) over the last 16 years, with FY2024 value amounting to $39.0 million.

  • Healthcare Services' EBITDA rose 17083.05% to $43.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.6 million, marking a year-over-year increase of 7236.04%. This contributed to the annual value of $39.0 million for FY2024, which is 255.13% down from last year.
  • As of FY2024, Healthcare Services' EBITDA stood at $39.0 million, which was down 255.13% from $40.0 million recorded in FY2023.
  • In the past 5 years, Healthcare Services' EBITDA ranged from a high of $101.3 million in FY2020 and a low of $26.8 million during FY2022
  • Its 5-year average for EBITDA is $50.8 million, with a median of $40.0 million in 2023.
  • As far as peak fluctuations go, Healthcare Services' EBITDA surged by 5046.48% in 2020, and later tumbled by 5363.48% in 2021.
  • Over the past 5 years, Healthcare Services' EBITDA (Annual) stood at $101.3 million in 2020, then crashed by 53.63% to $47.0 million in 2021, then plummeted by 43.03% to $26.8 million in 2022, then surged by 49.51% to $40.0 million in 2023, then decreased by 2.55% to $39.0 million in 2024.
  • Its last three reported values are $39.0 million in FY2024, $40.0 million for FY2023, and $26.8 million during FY2022.